GEISINGER LEWISTOWN HOSPITAL — History
CCN 390048 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$211M
Latest Revenue (FY2022)
+17.8%
Revenue CAGR (3yr)
11.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $152M | $181M | $211M | +16.6% | +17.8% |
| Operating Expenses | $136M | $164M | $187M | +13.9% | +17.4% |
| Operating Margin | 10.6% | 9.1% | 11.2% | +23.4% | +2.7% |
| Net Income | $16M | $16M | $24M | +43.9% | +21.0% |
| Licensed Beds | 119 | 119 | 107 | -10.1% | -5.2% |
| Total Patient Days | 18,385 | 23,113 | 21,243 | -8.1% | +7.5% |
| Medicare Day % | 29% | 27% | 26% | -3.4% | -5.8% |
| Medicaid Day % | 5% | 3% | 3% | -4.9% | -15.5% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +38.8% ($152M → $211M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+17.8%
This Hospital
+7.6%
State Avg
Latest Margin
11.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $240M | 11.5% |
| FY2024 (proj) | $270M | 11.8% |
| FY2025 (proj) | $299M | 12.1% |